Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2022-05-31 Earnings Release
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Preliminary results
Earnings Release Classification · 100% confidence The document explicitly states it announces the "Preliminary Results for Year Ended 31 December 2021" for Eden Research plc. It contains detailed financial highlights (Revenue, Loss before tax, EBITDA, Cash position) and operational highlights for the year. This content structure is characteristic of an Annual Report or a comprehensive report covering a full fiscal year. However, the document is titled as 'Preliminary Results' and mentions that the 'full Financial Statements are available at: [www.edenresearch.com]'. This suggests it is a summary announcement of the annual results, rather than the full, audited 10-K filing itself. Given the options, the closest fit for a comprehensive annual results announcement that is not the full 10-K is often classified as an Earnings Release (ER) if it were quarterly, but since this covers the full year and includes Chairman/CEO statements typical of an annual review, it strongly aligns with the content of an Annual Report (10-K) or a comprehensive Interim Report (IR) if it were half-yearly. Since it covers the full year and is a detailed summary of performance, it is most likely the company's primary annual results disclosure before the final 10-K filing, which often falls under the scope of an Earnings Release (ER) for initial announcements, or sometimes an Interim Report (IR) if the jurisdiction uses that term broadly. Given the depth and the 'Preliminary' nature, it functions as the primary annual earnings announcement. If the document were the full statutory filing, it would be 10-K. Since it is the announcement of the results, ER is the most appropriate code for the initial release of annual figures, even though it covers a full year. If the document were significantly shorter and only pointed to the full report, RPA would be chosen, but this text is substantial and contains the core results and commentary. Therefore, ER is selected as the best fit for the initial announcement of annual financial performance highlights. FY 2021
2022-05-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 6749L' and contains the standard boilerplate text indicating it is provided by 'RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing a change in voting rights held by Amati Global Investors Limited, crossing a threshold. This type of mandatory disclosure to the market, especially when originating from the RNS system, falls under the general regulatory announcement category. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit, as TR-1 forms are the standard mechanism for reporting major shareholdings crossing notification thresholds in the UK.
2022-05-16 English
Regulatory update
Environmental & Social Information Classification · 99% confidence The document is identified by the header 'RNS Number : 8493K' and contains a regulatory update regarding EPA approval progress and authorization in Italy for biopesticides. It is a formal announcement disseminated via RNS (Regulatory News Service), which is the news service of the London Stock Exchange. Since the content is a specific operational/regulatory update that doesn't fit neatly into the defined categories like 10-K, ER, or IR, and it is clearly a regulatory announcement distributed through the official channel, the most appropriate classification is the general regulatory filing category, RNS.
2022-05-10 English
Trading Update
Earnings Release Classification · 99% confidence The document is identified by the RNS Number (2897D) and the header indicating it is distributed via RNS, the news service of the London Stock Exchange. The content is titled 'Trading Update' and provides unaudited financial highlights (sales, revenue, loss before tax, cash position) for the year ended 31 December 2021, along with operational updates. This format—a brief, periodic update on financial performance released via a regulatory news service—most closely aligns with an Earnings Release (ER), which covers key highlights for a period. Although it contains financial data, it is explicitly labeled as a 'Trading Update' and is not the comprehensive Annual Report (10-K) or the detailed Interim Report (IR). Since it is a direct financial performance announcement, ER is the best fit over the general regulatory filing category (RNS). FY 2021
2022-03-02 English
New Major Crop Use for Mevalone in France
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number' and is dated '02 December 2021'. It announces a specific operational update: 'New Major Crop Use for Mevalone® in France' granted by the French regulatory authority ANSES. The text concludes with standard boilerplate information from RNS, the news service of the London Stock Exchange, and mentions that RNS is approved by the Financial Conduct Authority (FCA). This structure—a brief announcement of a specific, material event disseminated via the official regulatory news service—is characteristic of a general regulatory announcement that doesn't fit into the more specific categories like Earnings Release (ER) or Annual Report (10-K). Since it is a specific regulatory announcement that doesn't fit other defined categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback is Regulatory Filings (RNS). The document length is moderate (6871 chars), but the content is a direct announcement rather than a detailed report, making RNS suitable.
2021-12-02 English
Admission to the US OTC Market
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated October 20, 2021. The content announces that Eden Research plc's shares will commence trading on the U.S. OTCQB Venture Market under the ticker EDNSF. This is a specific corporate action announcement related to market listing/trading venue change, which is not explicitly covered by the primary definitions like 10-K, ER, or IR. Since it is a formal announcement distributed via RNS (as indicated by the header and footer), and it doesn't fit into the more specific categories like Capital/Financing Update (CAP) or Delisting (DLST), the most appropriate general category for a non-standard regulatory announcement distributed through the RNS system is 'Regulatory Filings' (RNS). It is not a report itself, but a notification.
2021-10-20 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.